Pituitary Surgery

The Pituitary

Volumn , Issue , 2011, Pages 703-719

  Fahlbusch, Rudolf ^a   Buchfelder, Michael ^b  

^a INTERNATIONAL NEUROSCIENCE INSTITUTE   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882550798     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-380926-1.10021-5     Document Type: Chapter

References (111)

1. Horsley V. On operative technique of operations on the central nervous system. Br Med J 1906, 2:411-423.
2. Kiliani O.G.T. Some remarks on tumors of the chiasm, with a proposal on how to reach the same by operation. Ann Surg 1904, 40:35-43.
3. Frazier C.H. Choice of method in operations upon the pituitary body. Surg Gynecol Obstet 1919, 29:9-16.
4. Frazier C.H. Lesions of the hypophysis from the viewpoint of a surgeon. Surg Gynecol Obstet 1913, 17:724-736.
5. Dandy W.E. A new hypophysis operation. Bull Johns Hopkins Hosp 1918, 29:151-155.
6. Dandy W.E. The brain. Practise of Surgery 1934, 556-605. WF Prior, Hagerstown, MD. D. Lewis (Ed.).
7. Schloffer H. Erfolgreiche Operation eines Hypophysentumors auf nasalem Wege. Wien Klin Wochensch 1907, 20:621-624.
8. von Eiselsberg A.H. Über den Endausgang und Obduktion meines ersten operativen Falles von Hypophyentumor. Beitr Pathol Anat 1922, 71:619-624.
9. von Eiselsberg A.H. My experience about operation upon the hypophysis. Ann Surg 1910, 52:1-14.
10. Hirsch O. Endonasal method of removal of hypophyseal tumors: With report of two cases. JAMA 1910, 55:772-774.
11. Hirsch O. Über Methoden der Behandlung von Hypophysistumoren auf endonasalem Wege. Arch Laryngol Rhinol 1911, 24:129-177.
12. Cushing H. Partial hypophysectomy for acromegaly: With remarks on the functions of the hypophysis. Ann Surg 1909, 50:1002-1017.
13. Cushing H. Intracranial tumours. Notes upon a series of two thousand verified cases with surgical-mortality percentages pertaining thereto 1932, Ch.C. Thomas, Springfield, pp. 69-79.
14. Guiot G., Arfel G., Brion S., et al. Adenomes hypophysarires 1958, Masson, Paris, pp. 1-276.
15. Guiot G. Considerations on the surgical treatment of pituitary adenomas. Treatment of pituitary adenomas 1978, 202-218. Thieme, Stuttgart. R. Fahlbusch, K. von Werder (Eds.).
16. Knosp E., Steiner E., Kitz K., Matula C. Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993, 33:610-617.
17. Buchfelder M., Fahlbusch R., Nomikos P., et al. Recent Advances in CT and MRI in the diagnosis and follow-up of hypothalamo-pituitary disease. Pituitary adenomas 1996, 132-145. Excerpta Media Elsevier, Amsterdam. K. von Werder, R. Fahlbusch (Eds.).
18. Rhoton A.L., Hardy D.G., Chambers S.M. Microsurgery anatomy and dissection of the sphenoid bone, cavernous sinus and sellar region. Surg Neurol 1979, 12:63-104.
19. Rhoton A.L., Harris F.S., Rehn W.H. Microsurgical anatomy of the sellar region and cavernous sinus. Clin Neurosurg 1977, 24:54-85.
20. Buchfelder M., Fahlbusch R. The "classic" transsphenoidal approach for resection of pituitary tumors. Operat Techn Neurosurg 2002, 5:210-217.
21. Dolenc V.V. Transcranial epidural approach to pituitary tumors extending beyond the sella. Neurosurgery 1997, 41:542-550.
22. Fahlbusch R., Buchfelder M. Surgical complications. Pituitary adenoma 1996, 395-408. Churchill Livingstone, New York. A.M. Landolt, M.L. Vance, P.L. Reilly (Eds.).
23. Tsang R.W., Brierley J.D., Panzarella T., et al. Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol 1996, 41:45-53.
24. Pollock B.E., Kondzialka D., Lundsford L.D., Flickinger J.C. Stereotactic radiosurgery for pituitary adenomas: Imaging, visual and endocrine results. Acta Neurochir 1994, 62(Suppl):33-38.
25. Flickinger J.C., Nelson P.B., Taylor F.H., Robinson A. Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 1989, 63:2404-2408.
26. Fahlbusch R., Heigl T., Huk W.J., et al. The role of endoscopy and intraoperative MRI in transsphenoidal pituitary surgery. Pituitary adenomas 1996, 237-244. Excerpta Medica Elsevier, Amsterdam. K. von Werder, R. Fahlbusch (Eds.).
27. Buchfelder M., Fahlbusch R., Adams E.F., et al. Proliferation parameters for pituitary adenomas. Acta Neurochir 1996, 65(Suppl):18-21.
28. Burrow G.N., Wortzman G., Rewcastle N.B., et al. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981, 304:156-158.
29. Asa S.L. Tumors of the pituitary gland. Atlas of tumor pathology. Fascicle 22 1989, Armed Forces Institute of Pathology, Washington DC. third series ed.
30. Thapar K., Kovacs K., Laws E.R., Müller P.J. Pituitary adenomas: Current concepts in classification, histopathology and molecular biology. The Endocrinologist 1993, 3:39-57.
31. Sano T., Yamada S. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: Special reference to gonadotropin-positive adenomas. Pathol Int 1994, 44:697-703.
32. Colombo P., Ambrosi B., Saccomanno K., et al. Effects of long-term treatment with the gonadotropin-releasing hormone analog nafarelin in patients with non-functioning pituitary adenomas. Eur J Endocrinol 1994, 130:339-345.
33. Casanueva F.F., Molitch M.E., Schlechte J.A., et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2006, 65:265-273.
34. Bodner G.W., Atkin S.L., Savage M.W., et al. Effects of quinagolide (CV 205-502), a selective D2-agonist, on vascular reactivity in patients with a prolactin-secreting adenoma. Clin Endocrinol (Oxf) 1995, 43:49-53.
35. Webster J. Cabergoline and quinagolide therapy for prolactinomas. Clin Endocrinol (Oxf) 2000, 53:549-550.
36. Ciccarelli E., Camanni F. Diagnosis and drug therapy of prolactinoma. Drugs 1996, 51:954-965.
37. Kreutzer J., Buslei R., Wallaschowski H., et al. Operative treatment of prolactinomas: Indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 2008, 158:11-18.
38. Fahlbusch R., Buchfelder M. Present status of neurosurgery in the treatment of prolactinomas. Neurosurg Rev 1985, 8:195-205.
39. Charpentier G., de Plunkert T., Jedynak P., et al. Surgical treatment of prolactinomas. Short- and long-term results, prognostic factors. Horm Res 1985, 22:222-227.
40. Guidetti B., Fraioli B., Cantore G.P. Results of surgical management of 319 pituitary adenomas. Acta Neurochir (Wien) 1987, 85:117-124.
41. Sano T., Asa S.L., Kovacs K. Growth hormone-releasing hormone producing tumors: Clinical, biochemical and morphological manifestations. Endocr Rev 1988, 9:357-373.
42. Wright A.D., Hill D.M., Lowy C., Fraser T.R. Mortality in acromegaly. Q J Med 1970, 39:1-16.
43. Plewe O., Beyer J., Krause U., et al. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet 1984, 2:782-784.
44. Morange I., De Boisvilliers F., Chanson P., et al. Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide. J Clin Endocrinol Metab 1994, 79:145-151.
45. Barkan A.L. Acromegaly. Diagnosis and therapy. Endocrinol Metab Clin North Am 1989, 18:277-310.
46. Melmed S., Colao A., Barkan A., Molitch M., et al. Acromegaly Consensus Group: Guidelines for acromegaly management: An update. J Clin Endocrinol Metab 2009, 94:1509-1517.
47. Giustina A., Barkan A., Casanueva F.F., et al. Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 2000, 85:526-529.
48. Nomikos P., Buchfelder M., Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical cure. Eur J Endocrinol 2005, 152:379-387.
49. Davis D.H., Laws E.R., Ilstrup D.M., et al. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 1993, 79:70-75.
50. Bates P.R., Carson M.N., Trainer P.J., Wass J.A. UK National Acromegaly Register Study Group (UKAR-2): Wide variation in surgical outcomes for acromegaly in the UK. Clin Endocrinol (Oxf) 2008, 68:136-142.
51. Aron D.C., Findling J.W., Tyrrell J.B. Cushing's disease. Endocrinol Metab Clin North Am 1987, 16:705-730.
52. Orth D.N. Cushing's syndrome. N Engl J Med 1995, 332:791-803.
53. Biller B.M., Grossman A.B., Stewart P.M., et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2008, 93:2454-2462.
54. Fahlbusch R., Buchfelder M., Müller O.A. Transsphenoidal surgery for Cushing's disease. J Royal Soc Med 1986, 79:262-269.
55. Chandler W.F., Schteingart D.E., Lloyd R.V., et al. Surgical treatment of Cushing's disease. J Neurosurg 1987, 66:204-212.
56. Mampalam T.J., Tyrrell J.B., Wilson C.B. Transsphenoidal microsurgery for Cushing's disease. A report of 216 cases. Ann Intern Med 1988, 109:487-493.
57. Guilhaume B., Bertagna X., Thomsen M., et al. Transsphenoidal pituitary surgery for the treatment of Cushing's disease: Results in 64 patients and long-term follow-up studies. J Clin Endocrinol Metab 1988, 66:1056-1064.
58. Patel C.G., Prevedello D.M., Lad S.P., et al. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 2008, 93:358-362.
59. Hofmann B.M., Hlavac M., Kreutzer J. Surgical treatment of recurrent Cushing's disease. Neurosurgery 2006, 58:1108-1118.
60. Nelson D.H., Meakin J.W., Dealy J.B., et al. ACTH producing tumor of the pituitary gland. Ann Intern Med 1958, 52:560-569.
61. Buchfelder M., Fahlbusch R., Thierauf P., Müller O.A. Observations on the pathophysiology of Nelson's syndrome: A report of three cases. Neurosurgery 1990, 27:961-968.
62. Beck-Peccoz P., Persani L. TSH-induced hyperthyroidism caused by a pituitary tumor. Nat Clin Pract Endocrinol Metab 2006, 2:524-528.
63. Comi R.J., Gesundheit N., Murray L., et al. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 1987, 319:12-17.
64. Molitch M.E. Gonadotroph-cell pituitary adenomas (editorial; comment). N Engl J Med 1991, 324:626-627.
65. Thapar K., Kovacs K., Scheithauer B.W., et al. Classification and pathology of sellar and parasellar tumors. The practice of neurosurgery 1996, 1021-1070. Williams & Willkins, Baltimore. G.T. Tindall, P. Cooper, D.L. Barrow (Eds.).
66. Fahlbusch R., Honegger J., Paulus W., et al. Surgical treatment of craniopharyngiomas: Experience with 168 patients. J Neurosurg 1999, 90:237-250.
67. Honegger J., Buchfelder M., Fahlbusch R. Surgical treatment of craniopharyngiomas: Endocrinological results. J Neurosurg 1999, 90:251-257.
68. Fischer E.G., Welch K., Shillito J., et al. Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 1990, 73:534-540.
69. Raimondi A.J. Craniopharyngioma: Complications and treatment failures weaken case for aggressive surgery. Crit Rev Neurosurg 1993, 3:7-24.
70. Cushing H., Eisenhardt L. Meningiomas. Their classifications, regional behaviour, life history and surgical end results 1938, Charles C. Thomas, Springfield IL, pp. 298-319.
71. Sekhar L.N., Sen C.N., Jho H.D., Janecka I.P. Surgical treatment of intracavernous neoplasms: A four-year experience. Neurosurgery 1989, 24:18-30.
72. Honegger J., Fahlbusch R., Buchfelder M., et al. The role of transsphenoidal microsurgery in the management of sellar and parasellar meningioma. Surg Neurol 1993, 39:18-24.
73. Akutsu H., Kreutzer J., Fahlbusch R., Buchfelder M. Transsphenoidal decompression of the sellar floor for cavernous sinus meningiomas: Experience with 21 patients. Neurosurgery 2009, 65:54-62.
74. Schrell U.M., Rittig M.G., Anders M., et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 1997, 86:845-852.
75. McGrath B. Cysts of sellar and pharyngeal hypophyses. Pathology 1971, 3:123-131.
76. Voelker J.L., Campbell R.L., Muller J. Clinical, radiographic and pathological features of symptomatic Rathke's cleft cysts. J Neurosurg 1991, 74:535-544.
77. Nomikos P., Buchfelder M., Fahlbusch R. Intra- and suprasellar colloid cysts. Pituitary 1999, 2:123-125.
78. Baskin D.S., Wilson C.B. Transsphenoidal treatment of non-neoplastic intrasellar cysts. A report of 38 cases. J Neurosurg 1984, 60:8-13.
79. Jafar J., Crowell R. Parasellar and optic nerve lesions: The neurosurgeon's perspective. Radiol Clin North Am 1987, 25:877-885.
80. Rutka J., Hoffman H., Drake J. Suprasellar and sellar tumors in childhood and adolescence. Neurosurg Clin N Am 1992, 3:103-115.
81. Roessmann U., Kaufman B., Friede R.T. Metastatic lesions in the sella turcica and pituitary gland. Cancer 1970, 25:478-480.
82. Teears R.J., Silverman E.M. Clinicopathologic review of 88 cases of carcinoma metastatic to the pituitary gland. Cancer 1975, 36:216-220.
83. Maiuri B. Primary cerebral lymphoma presenting as steroid-responsive chiasmal syndrome. Br J Neurosurg 1987, 1:499-502.
84. Dhanani A.-N.N., Bilbao J.M., Kovacs K. Multiple myeloma presenting as a sellar plasmocytoma and mimicking a pituitary tumor: Report of a case and review of the literature. Endocr Pathol 1990, 1:245-248.
85. Wold L.F., Laws E.R. Cranial chordomas in children and young adults. J Neurosurg 1983, 59:1043-1047.
86. Cosman F., Post K.D., Holub D.A., Wardlaw S.L. Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine Baltimore 1989, 68:240-256.
87. Asa S.L., Bilbao J.M., Kovacs K., et al. Lymphocyic hypophysitis of pregnancy resulting in hypopituitarism. Ann Intern Med 1981, 95:166-171.
88. Honegger J., Fahlbusch R., Bornemann A., et al. Lymphocytic and granulomatous hypophysitis, experience with nine cases. Neurosurgery 1997, 40:713-722.
89. Gutenberg A., Hans V., Puchner M.J., et al. Primary hypophysitis: Clinical-pathological correlations. Eur J Endocrinol 2006, 155:101-107.
90. Berger S.A., Edberg S.C., David G. Infectious disease in the sella turcica. Rev Infect Dis 1986, 8:747-755.
91. Albright A.L., Lee P.A. Neurosurgical treatment of hypothalamic hamartoma causing precocious puberty. J Neurosurg 1993, 78:77-82.
92. Asa S.L., Scheithauer B.W., Bilbao J.M., et al. A case for hypothalamic acromegaly: A clinico-pathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 1984, 58:796-803.
93. Georgakoulias N., Vize C., Jenkins A., Singounas B. Hypothalamic hamartomas causing gelastic epilepsy: Two cases and a review of the literature. Seizure 1998, 7:167-171.
94. Stewart L., Steinbok P., Daaboul J. Role of surgical resection in the treatment of hypothalamic hamartomas causing precocious puberty. Report of six cases. J Neurosurg 1998, 88:340-345.
95. Jennings M.T., Gelman R., Hochberg F. Intracranial germ-cell tumors: Natural history and pathogenesis. J Neurosurg 1985, 63:155-167.
96. Buchfelder M., Fahlbusch R., Walther M., Mann K. Endocrine disturbances in suprasellar germinomas. Acta Endocrinol (Copenh) 1989, 120:337-342.
97. Baumgartner J.E., Edwards M.S. Pineal tumors. Neurosurg Clin N Am 1992, 3:853-862.
98. Boggan J.E., Davis R.L., Zorman G., Wilson C.B. Intrasellar epidermoid cyst. Case report. J Neurosurg 1983, 58:411-415.
99. Jho H.D., Carrau R.L. Endoscopic endonasal transsphenoidal surgery. J Neurosurg 1997, 87:44-51.
100. Rudnik A., Kos-Kudla B., Larysz D., et al. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas. Neuro Endocrinol Lett 2007, 28:438-444.
101. Zada G., Kelly D.F., Cohan P., et al. Endonasal transspenoidal approach for pituitary adenomas and other sellar lesions: An assessment of efficacy, safety and patient impressions. J Neurosurg 2003, 98:350-358.
102. Cavallo L.M., Prevedello D.M., Solari D., et al. Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas. J Neurosurg 2009, 111:578-589.
103. Elias W.J., Chadduck J.B., Alden T.D., Laws E.R. Frameless stereotaxy for transsphenoidal surgery. Neurosurgery 1999, 45:271-275.
104. Carvi Y., Nievas M.N., Höllerhage H.G. Reliability of neuronavigation-assisted trans-sphenoidal tumor resection. Neurol Res 2007, 29:557-562.
105. Yamasaki T., Moritake K., Hatta J., Nagai H. Intraoperative monitoring with pulse Doppler ultrasonography in transsphenoidal surgery: Technique application. Neurosurgery 1996, 38:95-97.
106. Bohinski R.J., Warnick R.E., Gaskill-Shipley M.F., et al. Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery 2001, 49:1133-1143.
107. Fahlbusch R., Ganslandt O., Buchfelder M., et al. Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg 2001, 95:381-390.
108. Nimsky C., Ganslandt O., Fahlbusch R. Comparing 0.2 tesla with 1.5 tesla intraoperative magnetic resonance imaging analysis of setup, workflow and efficiency. Acad Radiol 2005, 12:1065-1079.
109. Nimsky C., von Keller B., Ganslandt O., Fahlbusch R. Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 2006, 59:105-114.
110. Barker F.G., Klibanski A., Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: Mortality, morbidity and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 2003, 88:4709-4719.
111. Mortini P., Losa M., Barzaghi R., et al. Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 2005, 56:1222-1233.